Imaging Diagnosis Expert Professor Gong Xiangyang Confirms Participation in MTWF 2018 Medical Technology World Forum

Hosted by VCBeat, Eggshell Research Institute, and the Industry-Academia-Research Cooperation Coordination Department of the China High-Tech Industrialization Research Association“Infinity” – The 2018 World Forum on Medical Technology will be held at the Le Méridien Minhang, Shanghai from September 26 to 27.

Professor Gong Xiangyang, Deputy Dean of the School of Medical Imaging at Hangzhou Medical College and Director of the Department of Radiology at Zhejiang Provincial People’s Hospital (Chief Physician), has confirmed his attendance at “Infinity” – The 2018 World Forum on Medical Technology.

[Profile]

Deputy Dean and Professor, School of Medical Imaging, Hangzhou Medical College; Director and Chief Physician, Department of Radiology, Zhejiang Provincial People’s Hospital. He is one of the earliest radiology experts in China to engage with artificial intelligence in medical imaging, and his pioneering work has been featured by CCTV, The New York Times, and various online and print media outlets. With over 25 years of experience in diagnostic imaging and interventional therapy, he is well-versed in the comprehensive application of various imaging techniques, including X-ray, CT, and MRI. He has managed a large number of complex and challenging cases, accumulating extensive clinical expertise. He possesses particular proficiency in three subspecialty areas: musculoskeletal imaging, neuroimaging, and the application of novel magnetic resonance imaging (MRI) technologies.

Professor Gong Xiangyang believes that a correct mindset toward AI in healthcare is essential: First,When doctors have sufficient trust in AI, it indicates that the technology has become relatively capable and intelligent, with a low error rate., which is the prerequisite; second,Industry standards and laws and regulations are required for oversight.; Third,A certain degree of tolerance for error is required.。

Professor Gong Xiangyang believesOnly AI with practical applications holds significance! And the way to determine whether AI companies are truly helping doctors solve actual clinical pain points is simple, which isCan it be embedded into the actual workflow of physicians and adopted for clinical use?Can it truly assume part of physicians’ workload, improve their work efficiency, and reduce their labor burden?

On September 26, Professor Gong Xiangyang, Deputy Dean of the School of Medical Imaging at Hangzhou Medical College, will attend the “Infinity” – 2018 World Forum on Medical Technology, co-hosted by VCBeat, VBInsight, and the Industry-Academia-Research Cooperation Coordination Department of the China High-Tech Industrialization Research Association. He will deliver an on-site presentation on how artificial intelligence is driving physicians to evolve to higher levels of professional competence.

Scan the QR code to register. Early-bird tickets are on limited-time offer...

[Conference Details]

We can now see that digital technologies such as artificial intelligence, robotics, 3D printing, and the Internet of Things are impacting various industries, with continuous technological innovation disrupting the healthcare sector.

With the introduction of the “Development Plan for New Generation Artificial Intelligence” and the “Guiding Opinions on Promoting the Development of ‘Internet + Healthcare’,” capital has flooded into the sector, leading to the frequent emergence of highly valued AI enterprises, while commercialization pathways continue to be explored.

The “Healthy China 2030” Planning Outline was released, and three major health and medical data groups were established; the explosive growth in data, driven by declining costs of data acquisition from gene sequencing and wearable devices, has laid a scalable foundation for big data and AI analytics.

As the application of robots in China’s healthcare sector gains increasing recognition and becomes more widespread across various stages of diagnosis and treatment, medical robots—particularly surgical robots—have emerged as “high-demand products” within the robotics industry. Robotic systems are being increasingly deployed in hospitals, with domestic technologies steadily catching up with their foreign counterparts.

Medical 3D printing has entered a transitional phase from its initial to intermediate stage. Dental restoration and customized prosthetics have already achieved commercialization and are developing rapidly. Orthopedics has become a key battleground for market competition, attracting various enterprises to establish their presence. Breakthroughs have been made in organ and tissue experiments, making human clinical applications promising.

In April this year, the National Health Commission released the “Standards and Specifications for Hospital Information Construction in China (Trial),” which clearly defines 21 application scenarios for IoT-based positioning and data monitoring. With the introduction of these standards, the direction of the IoT industry has become increasingly clear, and scenario-based applications are beginning to stand out.

In the genetics sector, tumor detection is poised for rapid growth, microbiomics is gradually maturing under policy guidance, and consumer genetic testing has entered the “20-yuan” era.

Technological innovation enterprises have begun to explore their own paths for application implementation, scaling from 1 to N...

The 2018 World Forum on Medical Technology, themed “Infinity,” will be held at the Le Méridien Shanghai, Minhang from September 26 to September 27, 2018.

This forum will bring together domestic and international healthcare service providers, listed companies, financial institutions, and health-tech innovators with a core focus on technological innovation. Discussions will center on five key dimensions: policy, capital, data, technology, and commercialization pathways. The event will explore the commercial applications of five major technologies—artificial intelligence, big data, robotics, 3D printing, and IoT, alongside genetic testing—within hospitals, pharmaceutical companies, and third-party healthcare service providers. The agenda features eight core forums covering over 80 hot topics, gathering more than 80 distinguished guests, 100+ investors, 300+ entrepreneurs, and 30+ media outlets in Shanghai to spark intellectual exchange and foster collaboration.

If you are a government official, healthcare practitioner, or industry professional focused on technological innovation in health and medical care—including executives from healthcare IT companies, medical device manufacturers, pharmaceutical firms, and insurance companies; industry investors; healthcare media professionals; and leaders of public or startup companies engaged in big data and AI-powered healthcare—this industry forum is tailor-made for “you.”

You’re Just One Ticket Away from Industry Titans

Scan the QR code to register. Limited-time early bird tickets are now available...